Biohaven in recent months has reported a clinical stumble in spinal muscular atrophy, alongside a Phase I readout for its ...
13 小时
GlobalData on MSNBiohaven’s pivotal bipolar drug trial fails, stock takes hitBiohaven’s pipeline drug BHV-7000 has failed to meet the primary endpoint in a pivotal Phase II/III bipolar trial, sinking ...
People with bipolar disorder who followed a ketogenic diet for at least six weeks found that their symptoms improved, a new ...
Treating bipolar disorder can be complex, and doctors may prescribe several medications. One way to treat bipolar disorder is with antidepressants, which increase neurotransmitters in the brain.
For 4.8 million Americans with bipolar I disorder, consistent treatment prevents severe mood swings; experts share six ...
Before lithium became available to treat this potentially devastating illness, bipolar I sufferers experienced repeated ...
6 天
Medpage Today on MSNGlobal Suicides; Drug Overdose Deaths Drop; Keto Diet for Bipolar Disorder?The FDA is reviewing risperidone (Uzedy) extended-release injectable suspension for maintenance treatment of adults with ...
Usually, the core treatment for bipolar disorder is a combination of medication and psychotherapy. CBT is one of the more common types of psychotherapy. CBT can help treat bipolar disorder by ...
University of Cincinnati researchers explore whether ketogenic diet combined with standard medications can improve bipolar ...
4 小时
Investor's Business Daily on MSNBiohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion OpportunityBiohaven stock tumbled for the second day running Tuesday after its bipolar mania treatment failed in a three-week study.
The application leverages existing clinical data for Uzedy along with prior FDA findings on the safety of Udezy in patients ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果